Canadian mining firm Ascot Resources (TSX:AOT,OTCQX:AOTVF) is pressing forward with a financing strategy aimed at getting back on course at its Premier Northern Lights...
The Ontario government has announced C$13 million in funding through its Ontario Junior Exploration Program (OJEP) to support early stage exploration efforts by 84...
In an industry poised to transform customer engagement, Syntheia (CSE:SYAI) is an innovative conversational AI solution addressing the complex needs of modern communication. Designed...
GMV Minerals Inc. (the ‘Company’ or ‘GMV’) (TSXV:GMV)(OTCQB:GMVMF) is pleased to announce that preliminary results from the four drill holes completed on the Daisy...
Nordic Nickel Limited (ASX: NNL; Nordic, or the Company) is pleased to announce extremely positive results from its first pass metallurgical testing program for...
Hemlock Semiconductor (HSC) is set to enhance its operational capacity in Michigan, US, after the announcement of a preliminary agreement for a US$325 million...
IsoEnergy (TSX:ISO,OTCQX:ISENF) and Purepoint Uranium (TSXV:PTU,OTCQB:PTUUF) have formed a joint venture focused on the exploration and development of uranium properties in Saskatchewan’s Athabasca Basin....
Overview True North Copper (ASX:TNC) is entering a transformative phase on our path to become Australia’s next copper producer. Mining activities have commenced at...
IsoEnergy Ltd. (TSX: ISO) (OTCQX: ISENF) (‘IsoEnergy‘) and Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) (‘Purepoint’) are pleased to announce that they have...
Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: SBMIF) (‘Lode Gold ‘ or the ‘Company’) is pleased to announce its wholly-owned subsidiary, (‘1475039 B.C. Ltd.’...
Key Assay Highlights: Total Samples Analyzed: 388 rock samples. Titanium Dioxide (TiO2): 49 samples returned assay values over 4.0% TiO2, with a maximum value...
Quetzal Copper Corp. (TSXV: Q) (‘Quetzal’ or the ‘Company’) is pleased to announce the results from the Annual General Meeting (the ‘Meeting’) held on...
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with...